Instant Access with secure payment processing: $235 / One Month $975 / One Year Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Listing of Drug Product Information by Patent Expiration - 2018

Range: 1 - 5

Applicant Tradename Generic Name NDA Approval Date Type Patent Number Patent Expiration Patented / Exclusive Use Sanofi Aventis Us KETEK telithromycin 021144 Apr 1, 2004 RX 5,635,485 Apr 1, 2018 TREATMENT OF COMMUNITY ACQUIRED PNEUMONIA, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, AND ACUTE BACTERIAL SINUSITIS CAUSED BY SUSCEPTIBLE STRAINS OF DESIGNATED MICROORGANISMS IN PATIENTS 18 YEARS AND OLDER. Sanofi Aventis Us KETEK telithromycin 021144 Feb 9, 2005 RX 5,635,485 Apr 1, 2018 TREATMENT OF COMMUNITY ACQUIRED PNEUMONIA, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, AND ACUTE BACTERIAL SINUSITIS CAUSED BY SUSCEPTIBLE STRAINS OF DESIGNATED MICROORGANISMS IN PATIENTS 18 YEARS AND OLDER. Gd Searle CELEBREX celecoxib 020998 Aug 29, 2002 RX 5,972,986 Apr 14, 2018 Gd Searle CELEBREX celecoxib 020998 Dec 31, 1998 RX 5,972,986 Apr 14, 2018 Medicis LOPROX ciclopirox 020519 Jul 21, 1997 RX 7,026,337 Apr 2, 2018 TOPICAL TREATMENT OF INTERDIGITAL TINEA PEDIS AND TINEA CORPORIS DUE TO TRICHOPHYTON RUBRUM, TRICHOPHYTON MENTAGROPHYTES OR EPIDERMOPHYTON FLOCCOSUM

 Complete access available with subscription